Human cytomegalovirus (HCMV), strain AD169, contains four genes (US27, US28, UL33, and UL78) that encode putative homologues of cellular G protein-coupled receptors (GCRs). GCRs transduce extracellular signals to alter intracellular processes, and there is evidence that HCMV may elicit such changes at early times following infection. The US27, US28, and UL33 genes are transcribed during infection, and the US28 gene product has been found to be a functional receptor for the b-chemokine class of immune modulators. The US27, UL33, and UL78 gene products have not been described and we have concentrated on identifying the UL33 protein because it is the most highly conserved of the GCR homologues among the human b and g herpesviruses. We report here cloning UL33 into a recombinant baculovirus (rBV) and expressing it in insect cells; constructing a mutant HCMV with a disrupted UL33 gene; and identifying the UL33 protein in HCMVinfected cells and virus particles. Our results demonstrate that the UL33 protein (i) is expressed as a É36-kDa, heataggregatable protein in rBV-infected cells, (ii) is modified heterogeneously by asparagine-linked glycosylation and expressed as a §58-kDa glycoprotein that is present in the region of the cytoplasmic inclusions in HCMV-infected fibroblasts, (iii) is present in virions and two other enveloped virus particles, and (iv) is not essential for growth of HCMV in human foreskin fibroblast cultures. ᭧
INTRODUCTION
loop, thought to be necessary for the receptor -G protein interaction (Oliveira et al., 1993) , and other conserved Human cytomegalovirus (HCMV) is a member of the residues throughout are commonly found (Fraser et al., herpesvirus family (human herpesvirus 5) and is a ubiqui-1994; Horuk, 1994) . tous pathogen that causes many disorders in immunodeGCRs are typically the first members involved in a ficient or immunocompromised individuals and in neosignal transduction cascade initiated by ligand binding nates (Alford and Britt, 1990; Bruggeman, 1993) . Analysis and receptor activation; these ligands can be biogenic of the nucleotide sequence of the 230-kb genome of amines, peptides, odorants, tastants, or other signals HCMV strain AD169 (Chee et al., 1990a) revealed four (Fraser et al., 1994) . Ligand binding is predicted to alter open reading frames (ORFs), UL33, UL78, US27, and the conformation of a GCR, generating an active form US28, that potentially encode homologues of cellular G of the receptor, and dissociation of the ligand returns protein-coupled receptors (GCRs) (Attwood and Findlay, the GCR to an inactive state (Fraser et al., 1994) . There 1994; Chee et al., 1990b) , a family of signal transducing are also examples of constitutively activated, mutant proteins found in numerous biological systems (Attwood GCRs that are apparently fixed in an active conformaand Findlay, 1994; Kolakowski, 1994) . tion; these do not require ligand binding for activation GCRs characteristically have seven membrane-span- (Shenker, 1994) . ning domains and generally contain two disulfide-linked An activated GCR transmits its signal to a coupled cysteines in the second and third extracytoplasmic loops heterotrimeric G protein, which itself becomes activated (Fraser et al., 1994) ; multiple serines and threonines (Fra- and, in turn, alters the activity of target proteins; for examser et al., 1994) and a palmitoylated cysteine (Papac et ple, upregulating phosphatidylinositol phospholipase C al., 1992) in the intracellular, carboxyl tail; and aspara- (Sleight and Lieberman, 1995) , modulating adenylate cygine-linked glycosylation on extracellular domains (Fra- clase (Sleight and Lieberman, 1995) , or gating ion chanser et al., 1994) . In addition, an N-P-X-X-Y motif in the nels (Sleight and Lieberman, 1995; Yatani, 1995) are comseventh transmembrane domain (Berlose et al., 1994) , a mon effects. These affected proteins amplify and propaconserved D-R-Y sequence in the second intracellular gate the signal by altering the levels of small intracellular second messenger molecules, such as inositol trisphosphate, diacylglycerol, arachidonic acid, cyclic AMP (Sleight and Lieberman, 1995) . Examples of signal trans-(NIEPs), and dense bodies (DBs) were effectively purified, separated from one another, and concentrated by mission by second messengers include (i) liberating free calcium, to coordinate with calcium-binding proteins and banding three times in potassium tartrate gradients as documented previously (Irmiere and Gibson, 1983 ; Talbot increase calcium-dependent processes (Dedman and Kaetzel, 1995) , (ii) interacting with protein kinase C (PKC),
and Almeida, 1977) , except that the virus pellets were stored at 080Њ without solubilization. Spodoptera frugito activate other proteins (Sleight and Lieberman, 1995) , and (iii) interacting with cAMP-dependent proteins, to perda (Sf9) cells (ATCC CRL-1711) were grown and infected with baculovirus Autographa californica nuclear regulate transcription or other intracellular processes (Lalli et al., 1993; Sleight and Lieberman, 1995) .
polyhedrosis virus (AcNPV) as described (Gruenwald and Heitz, 1993; O'Reilly et al., 1992) . The recombinant bacuChanges in some second messengers have been noted during HCMV infection of human fibroblasts. Inloviruses (rBVs) rBV-33, rBV-Tag33, and rBV-N33 were prepared using the baculovirus transfer plasmids decreases of inositol trisphosphate, diacylglycerol, arachidonic acid, cAMP, calcium, and sodium, as well as inscribed below and plaque purified at least twice (Gruenwald and Heitz, 1993; O'Reilly et al., 1992) . creases of the transcription factors c-jun, c-myc, and cfos, have all been detected early in infection (Albrecht et al., 1991) , leading to the hypothesis that one or more of Construction of rBV transfer plasmids the virally encoded GCRs is responsible for these changes. Supporting such a relationship are data show-
The HCMV ORF UL33 (Chee et al., 1990a,b) was cloned through the polymerase chain reaction (PCR) (Scharf, ing that the HCMV US28 ORF encodes a functional bchemokine receptor that facilitates an increase of intra-1990) by using a plasmid containing the HindIII J fragment of HCMV, strain AD169 (gift of Marc Chee, Medical cellular calcium upon stimulation Neote et al., 1993) . The other HCMV GCRs encoded
Research Council), as a template and synthetic primers, with BamHI ends, which consisted of nucleotides 43246 -by US27 and UL33 are also most homologous to chemokine receptors (Horuk, 1994 ; this report), proteins in-43269 for the coding strand and 44429-44453 for the complementary strand of the AD169 genome (Chee et volved in chemotaxis of monocytes and granulocytes (Ahuja et al., 1994; Durum and Oppenheim, 1993) . Since al., 1990a) . The plasmid BJM1 was made by inserting the resulting 1.2-kb UL33 PCR product into the BamHI site HCMV can be found in these cell types in vivo (Bruggeman, 1993; von Laer et al., 1995) , it is possible that HCMV of the vector pcDNA1 (Invitrogen, San Diego, CA). Subsequent dideoxy sequencing of the PCR-generated insert uses its own GCR homologues to take advantage of signal transduction pathways normally used by the host (Sequenase, United States Biochemical, Cleveland, OH) (Kraft et al., 1988) revealed one point mutation (base immune system. Because of the potential involvement of these GCRs in the pathology of HCMV infection, it is number 840 of the UL33 coding sequence, C for T), probably introduced by PCR (Smith et al., 1993) , that was not important to determine their function and mechanism of action.
repaired because it did not change the codon specificity for asparagine. We (Welch et al., 1991) and others (Davis-Poynter et al., 1995; Jones et al., 1995) have previously shown that A second plasmid, pTag33, that contained the ORF for an epitope-tagged version of the UL33 protein was made. the three ORFs, UL33, US27, and US28, are transcribed maximally in HCMV-infected fibroblasts at late times after The UL33 ORF from BJM1 was first cloned into the BamHI site of the vector pET-11c (Novagen, Madison, WI), creatinfection. In this report we have used Western immunoassays and indirect immunofluorescence to identify and to ing pET-33. BJM1 was then cut with HindIII, the 5 overhang filled with the large fragment of DNA polymerase I begin to characterize the protein product of the HCMV strain AD169 UL33 ORF.
(Klenow fragment, New England Biolabs, Beverly, MA), and cut with PvuI. The 5 coding region of the UL33 ORF (Initial reports of this work were presented at the 17th International Herpesvirus Workshop in Edinburgh, Scotfrom pET-33 (containing the coding sequence for an 11-amino-acid addition) was cut with NdeI, treated as above land, August 1-7, 1992 , and at the 20th International Herpesvirus Workshop in Groningen, the Netherlands, with a Klenow fragment, and subsequently cut with PvuI.
The blunt-to-PvuI fragment from pET-33 was subcloned July 30-August 3, 1995.) in place of the excised region of the UL33 ORF in BJM1, preserving the HindIII site. The plasmid pK-Tag33 was MATERIALS AND METHODS created by inserting a complementary pair of oligonucleCells and viruses otides containing a Kozak-consensus ATG start codon in place of the existing ATG initiating codon in pTag33 The propagation of human foreskin fibroblasts (HFF cells) and MRC5 cells and their infection with HCMV (Kaufman, 1990) : pTag33 was partially digested with NheI (Parker et al., 1977) and then cut with HindIII. The doublestrain AD169 (ATCC VR-538) have been described before (Gibson, 1981b; Kaye et al., 1992 ; Weiner and Gibson, stranded oligonucleotide, containing ends compatible with these same restriction sites and an internal BglII 1983). HCMV virions, noninfectious enveloped particles site 5 to the ATG, was then cloned into the prepared UL16 HCMV insertion mutants Kaye et al., 1992) . The correct insertion of lacZ sequences pTag33 vector.
pVL-33, the transfer plasmid for rBV-33, was conwithin the UL33 gene and the absence of contaminating wild-type virus were established by Southern hybridizastructed by cloning the UL33 ORF from BJM1 into the BamHI site of the baculovirus transfer vector pVL1393 tion (Sambrook et al., 1989) . HCMV plaque assays were done as described elsewhere . (Pharmingen, San Diego, CA). pVL-Tag33, the transfer plasmid for rBV-Tag33, was constructed by inserting the Preparation of UL33 antiserum and F(ab) 2 fragments 1.3-kb BglII-EcoRI extended UL33 ORF from pK-Tag33 into the corresponding sites of the baculovirus transfer Approximately 2 mg of a synthetic peptide corresponding to the predicted 17 carboxy-terminal amino acids of vector pVL1392 (Pharmingen). pVL-N33 is the rBV transfer plasmid for rBV-N33 and codes for a different aminothe protein encoded by UL33 (UL33 peptide, NH 2 -TKI-PHRLSQSHHNLSGV-CO 2 H) was coupled to 2 mg of keyterminally extended version of the UL33 protein; it was constructed as follows. First, an amino-terminal extenhole limpet hemocyanin (KLH; Pierce, Rockford, IL) via an EDC (1-ethyl-3-(dimethylaminopropyl) carbodiimide) sion of UL33 was generated by PCR; the template was the HCMV HindIII J fragment, cleaved with BfaI; the codbridge, according to the manufacturer (Imject kit; Pierce); this immunogen was named KLH-UL33. Also, 4 mg of ing strand primer included a BamHI site followed by the first 21 codons predicted in the longer, spliced mRNA for UL33 peptide was crosslinked to itself with 0.1% glutaraldehyde, essentially as described (Collawn and Paterson, UL33 (Davis-Poynter et al., 1995) ; the other primer for the complementary strand was an internal 20-mer previously 1995) , to create UL33-UL33. One female New Zealand white rabbit (Hazleton Research Products, Inc., Denver, used for sequencing. The final PCR product was cut with BamHI and DraIII and used to replace the BglII-DraIII PA) was immunized with a primary injection of 100 mg of KLH-UL33 in Freund's complete adjuvant, followed by fragment in pVL-Tag33.
Cloning and plasmid construction and purification was two similar boosts in Freund's incomplete adjuvant (IFA) (Harlow and Lane, 1988) . Subsequent boosts consisted done by standard techniques with strains MC1061/P3 (Invitrogen) and XL1-Blue (Stratagene, La Jolla, CA) of of 40 mg of UL33-UL33 in IFA. Serum was collected from the immunized animal periodically after at least six UL33-Escherichia coli (Sambrook et al., 1989; Scharf, 1990) . The composition and orientation of each construct was UL33 booster injections and stored at 080Њ until use; this antiserum was called rabbit anti-33. verified by restriction analyses and dideoxy sequencing (Kraft et al., 1988) when necessary. F(ab) 2 fragments were prepared as follows. The IgG fraction of the rabbit anti-33 antiserum was isolated by binding to a Fast-Flow Protein G Sepharose column (PharConstruction of UL33-disrupted HCMV macia, Piscataway, NJ) in 20 mM sodium phosphate buffer (pH 7.3), washing with 1 M NaCl in 20 mM sodium A mutant of HCMV that contains a disrupted UL33 ORF and is called HCMV D33 (D33) was made as follows.
phosphate buffer (pH 7.3), and eluting the IgG with 50 mM glycine-HCl (pH 3.0) in 5-ml fractions into tubes A fragment of the AD169 genome (nucleotides 38517 -46434) containing the UL33 coding region was cloned containing 500 ml of 1 M Tris -HCl (pH 7.5) (Harlow and Lane, 1988) . Fractions containing IgG were identified by in pUC13 to give pHBHJ. This plasmid was digested with AsuII which cleaves it once, 23 bp 3 of the ATG of sodium dodecyl sulfate -polyacrylamide gel electrophoresis (SDS-PAGE) and staining with Coomassie brilliant the UL33 ORF. A linker, constructed by annealing the oligonucleotides 5-CGAAAGATCTAGGCCTTT-3 and 5-blue (CBB), and the amount of protein present in each was measured by the BCA protein assay (Pierce). IgG-CGAAAGGCCTAGAT-3 was ligated into AsuII-cleaved and phosphatased pHBHJ to give pAsuII. The BglII site containing fractions were pooled, dialyzed overnight against 200 mM sodium acetate (pH 4.0), and treated present in the linker is unique in pAsuII, and a 3.8-kb BamHI fragment containing E. coli lacZ sequences downwith 100 mg pepsin (Boehringer-Mannheim, Indianapolis, IN)/mg IgG for 4 hr at 37Њ (Harlow and Lane, 1988; Hilstream of the CMV major immediate-early promoter derived from the plasmid pMV1 was dreth and Hyman, 1989). The preparation was neutralized with 0.05 vol of 1 M Tris -HCl (pH 7.5) and dialyzed overligated into BglII-cut and phosphatased pAsuII to give pUL33DgalE. This plasmid contains the lacZ gene in the night against calcium-and magnesium-free PBS (CMF-PBS). Fc fragments and incompletely cleaved IgG moleopposite transcription polarity to that of UL33. pUL33D-galE (2.5 mg) was linearized with BamHI and cotranscules were removed from the F(ab) 2 preparation by their binding to protein A-Sepharose beads (Sigma, St. Louis, fected with 20 mg of AD169-infected cell DNA into subconfluent monolayers of MRC5 cells by a modified cal-MO) in CMF-PBS. The remaining, unbound F(ab) 2 fragments, called rabbit F(ab) 2 Anti-33, were concentrated cium phosphate precipitation method (Chen and Okayama, 1987) . Resulting recombinant viruses were (Centricon 30; Amicon, Beverly, MA) and determined to be free of Fc fragments and IgG by SDS-PAGE and CBB identified by their blue-plaque phenotype, isolated, and plaque-purified as previously described for the UL18 and staining.
SDS -PAGE, peptide comparisons, and Western 8 days after infection with HCMV or 3 days after infection with rBVs. immunoassays
Cells were fixed with 3% paraformaldehyde (Poly-SDS -PAGE was done essentially as described presciences, Inc., Warrington, PA) in CMF-PBS and permeviously (Gibson, 1981b) . Exceptions were using 10 mM abilized with 0.5% Triton X-100 in TNgly (10 mM Trisdithiothreitol (DTT) instead of 10% b-mercaptoethanol in HCl (pH 7.4), 0.9% NaCl, and 10 mM glycine) (Machamer sample solubilizing buffer (Parker et al., 1993) and heatand Rose, 1988; Rose and Bergmann, 1982) . All subseing samples in a 42Њ water bath (instead of 100Њ) for 3 quent incubations were 35 min long at 25Њ and were min (Parker et al., 1993) , unless stated otherwise in the followed by three washes with TNgly (Harlow and Lane, text. Protein separations were in 12% polyacrylamide 1988). Slides were incubated with one of the following gels, and peptide-separating, second-dimension gels primary reagents, diluted in Western blocking buffer: nonwere 18% polyacrylamide, crosslinked with diallyltartardispecific rabbit serum (1:40), nonspecific rabbit F(ab) 2 (50 amide (DATD; Bio-Rad, Melville, NY) (Anker, 1970; Gib- mg/ml), nonspecific rabbit Fc (25 mg/ml), rabbit anti-33 son, 1981b). Peptide comparisons were done by twoantiserum (1:40), rabbit F(ab) 2 anti-33 (50 mg/ml), or dimensional SDS-PAGE followed by Western immunomouse anti-Tag (1:100). Peptide competition experiments assay, as previously described (Schenk et al., 1991) . Prowere done by adding a 1000-fold molar excess of either teins were cleaved at tryptophan residues, after excising UL33 peptide or C1 peptide (Schenk et al., 1991) to dithe lanes containing samples, by treatment in situ with luted rabbit F(ab) 2 anti-33, rocking the solution for 30 N-chlorosuccinimide (NCS; Aldrich, Milwaukee, WI) min at 25Њ, and subjecting the solution to centrifugation (Lischwe and Ochs, 1982; Schenk et al., 1991) . Immobi-(É8000 g, 25Њ, 1 min) to pellet insoluble material, all prior lon-P membranes were stained for the presence of proto use in the assay (Jemmerson and Hutchinson, 1990) . tein with 0.1% CBB in 50% acetic acid and 10% methanol,
The primary reagents were detected as specified, by as indicated.
incubation with goat IgG anti-rabbit (GAR)-lissamine rhoWestern immunoassays were done essentially as dedamine sulfonyl chloride (LRSC) (1:125), goat IgG antiscribed by Towbin et al. (1979) , using rabbit anti-33 (1:40), et al., 1996) , or mouse monoclonal anti-lower matrix progoat F(ab) 2 anti-rabbit Fc (GFARFc)-FITC (1:50). Each sectein (Anti-LM, 1:100; DuPont No. 9220), prepared in 5% ondary reagent reacted species-or antibody-fragment-BSA, 0.9% NaCl, 0.02% NaN 3 , and 10 mM Tris -HCl (pH specifically, and neither fluorochrome exhibited signifi-7.4) (Western blocking buffer), and detected with 125 Icant cross-excitation. All nonspecific sera, nonspecific labeled protein A (Amersham, Arlington Heights, IL)
IgG subfragments, and secondary reagent conjugates (Welch et al., 1993) . Specific electrotransfer conditions were purchased from Jackson ImmunoResearch. Covwere: Immobilon-P membrane (Millipore, Bedford, MA); erslips were attached to the processed slides with a drop 20% methanol, 50 mM Tris buffer; and transfer time calcuof Mowiol mounting medium, containing Mowiol 4-88 lated from the equation: transfer time equals gel length (Calbiochem, San Diego, CA No. 475904 ) and the anti-1 width 1 2.5 mA per 0.5 hr (Welch et al., 1993) . The fade agent DABCO (Sigma), prepared as described (Harmouse monoclonal antibody, anti-Tag (recognizes the T7-low and Lane, 1988), and cells were examined and photoTag epitope on the amino terminus of the UL33 protein graphed with an Olympus BH-2 microscope, equipped coded in the construct pET-33; Novagen), was diluted with a 40X SPlan objective lens, using Kodak Ektachrome 1:10,000 in Western blocking buffer and detected with 400 ASA color slide film rabbit anti-mouse IgG (10 mg/ml, Jackson ImmunoResearch, West Grove, PA), followed by 125 I-labeled protein Preparation of cells and membranes and treatment A. Fluorograms were prepared from the processed Imwith peptide N-glycosidase F mobilon-P sheets by using XAR-5 film (Eastman-Kodak, Rochester, NY) and a calcium-tungstate intensifying HCMV-infected, HCMV D33-infected, or noninfected screen at 080Њ (Laskey and Mills, 1977) .
HFF cells were recovered from 32-oz glass bottles (É5 1 10 7 cells/bottle) (Gibson, 1981b) 8 days after infection, Indirect immunofluorescence resuspended in CMF-PBS (1 ml/bottle), and frozen at 080Њ. rBV-infected cells were prepared similarly (É6 1 Each chamber of an Erie SuperCell 8 chamber slide was seeded with É6.25 1 10 4 HFF 10 6 cells/1 ml of CMF-PBS) and frozen at 080Њ. Cellular membranes were prepared from fresh or frozen cells cells or Sf9 cells. HFF cells were infected the next day with wild-type or D33 HCMV or left uninfected; Sf9 cells (Sung et al., 1991) that had been disrupted by forcing through a 27-gauge needle (Parker et al., 1993) . were infected with rBVs 20 min after seeding. Virus stocks were clarified by centrifugation at É8000 g for 1
For peptide N-glycosidase F (PNGase F) treatment, membrane preparations (20 mg of protein) were first incumin in a microfuge to pellet cellular debris before inoculating cultures. Immunofluorescence assays were done bated with 1/5 vol of freshly prepared 60 mM DTT, 12% (Haltiwanger and Hart, 1993; Sung et al., 1991; Tarentino and Plummer, 1994) . Treated samples were then prepared for SDS -PAGE and Western immunoassay by adding 1/3 vol of 41 solubilizing buffer.
RESULTS

Expression of the UL33 protein from recombinant baculoviruses
We began this work by first attempting to clone and identify the UL33 protein in a high-expression system. 
translational protein modifications and because it has
Whole cell lysates were prepared in solubilizing buffer and not heated been used successfully to express other cloned GCRs (lanes 1 -3, 7 -9) or heated in a boiling water bath (lanes 4 -6, 10 -12) (Mouillac et al., 1992; Parker et al., 1993; Zastawny et al., prior to SDS -PAGE. Western immunoassays were done with the anti-33 antiserum or anti-Tag antibody, as indicated. Circles are shown next 1994). We used the rabbit anti-33 anti-peptide antiserum to the Tag33 protein, detected by both anti-33 and anti-Tag. Arrow to detect the protein by Western immunoassay and imindicates GCR multimers. Molecular weight (in kDa) was estimated munofluorescence. We made and compared two rBVs, from molecular weight markers included during SDS -PAGE (Mark 12; one expressing the UL33 ORF (rBV-33, producing recomNovex, San Diego, CA) that were visualized by staining that portion binant UL33 protein, pUL33) and one expressing pUL33 of the Immobilon-P with Coomassie brilliant blue (CBB) immediately following electrotransfer.
with an 11-amino-acid epitope (T7 gene 10 sequence, detectable with a commercial mouse monoclonal antibody, anti-Tag) (Lutz-Freyermuth et al., 1990; Tsai et al., Fig. 1, lane 9) or heat-aggregated (Fig. 1, lane 12) , reacted Keene, 1992) fused to its amino end (rBV-Tag33, producwith the anti-Tag antibody, confirming its identity as the ing pTag33). Construction and use of these reagents is recombinant pTag33. The higher-molecular-weight imdescribed under Materials and Methods.
munoreactive material (e.g., see arrow, Fig. 1 ) is most Sf9 cells were infected with the recombinant baculovilikely multimers of pUL33 and pTag33 that did not dissoruses rBV-33 or rBV-Tag33, harvested in 21 SDS -PAGE ciate during SDS -PAGE (Sung et al., 1991) . No similar sample buffer 3 days later, and analyzed by SDS -PAGE protein was detected in wild-type BV-infected Sf9 cells and Western immunoassays (Fig. 1) . Two sets of samples (BV; lanes 1, 4, 7, 10). The presence of this protein only were analyzed in parallel; one was probed with rabbit in rBV-33-infected cells, its reaction with the anti-33 antianti-33 (Fig. 1, lanes 1 -6) and the other with mouse antiserum, and its size difference and reaction with the antiTag (Fig. 1, lanes 7 -12) . rBV-33 expressed a É36-kDa Tag antibody when fused with the 11-amino-acid epitope protein (Fig. 1, lane 2) , reactive with the anti-33 antiserum.
establish its identity as pUL33. rBV-Tag33 also expressed a protein that was immunoreactive with the anti-33 antiserum, but its size was slightly pUL33 expression from a recombinant baculovirus larger (i.e., É39 kDa, circle in Fig. 1, lane 3) due to the 11-amino-acid epitope added to its amino end. When
To investigate the localization of the recombinant UL33 protein, the previously characterized anti-33 antiserum heated in a boiling water bath, as usual prior to SDS -PAGE (Fig. 1, lanes 4-6 and 10-12) , both pUL33 and and anti-Tag antibody ( Fig. 1) were used in immunofluorescence assays of rBV-infected insect cells. Sf9 cells pTag33 formed high-molecular-weight aggregates that barely entered the resolving gel (e.g., Fig. 1 , lanes 5 and were infected with either wild-type baculovirus (BV), rBV-33, or rBV-Tag33 and 3 days later were subjected to 6), a phenomenon observed with other GCRs and highly hydrophobic proteins analyzed by SDS -PAGE (Semenza immunofluorescence assays with the anti-33 antiserum or anti-Tag antibody (Fig. 2) . rBV-33-infected cells et al., 1990). Only pTag33, whether monomeric (circle, showed a pattern of generalized extranuclear fluores- (Fig. 3K) . Nonspecific Fc binding is also shown in D33-infected cells (Fig. 3L) , demonstrating that although there cence ( Fig. 2A) that was absent from BV-infected cells assayed with the rabbit anti-33 antiserum (Fig. 2B) . rBVis no GCR33 in these cells, D33 still produces an Fcbinding component in the CIs during infection. This last Tag33-infected cells show the same pattern of fluorescence with both anti-33 and anti-Tag antibodies (Figs. control also shows that if Fc were present and the cause of reactivity in Figs. 3A and 3E, it would have been de-2C and 2D, respectively). The anti-Tag antibody also did not react with BV-infected cells (Fig. 2E) . The unequivocal tected with the anti-Fc-FITC reagent in Fig. 3F . The specificity of the interaction seen in Fig. 3A was identification of pTag33 by its unique epitope, and its coincident distribution, when visualized with the anti-33 also established by peptide competition experiments. An unrelated 21-amino-acid peptide, C1 (Schenk et al., or anti-Tag antibodies, establish both the specificity of the anti-33 antiserum for pUL33 and the nonnuclear lo-1991), was unable to compete rabbit anti-33 F(ab) 2 binding at a 1,000-fold molar excess (Fig. 3M ), but the 17-calization of pUL33.
amino-acid UL33 peptide at the same concentration completely blocked the interaction (Fig. 3N) . Together, these GCR33 localizes to cytoplasmic inclusion structures results show that the rabbit F(ab) 2 anti-33 preparation in HCMV-infected cells specifically reacts with GCR33 in immunofluorescence Having verified the specificity of the anti-33 antiserum experiments, that GCR33 localizes to the CI region of and determined some properties of pUL33 expressed in HCMV-infected cells, and that GCR33 is not responsible rBVs, we next attempted to identify the UL33 protein in for the Fc binding that defines the region of the infected-HCMV-infected fibroblasts. The UL33 protein expressed cell CIs. in HCMV-infected cells was called GCR33, to distinguish it from the recombinant form of the protein, pUL33. Immu-GCR33 is É43 kDa and exhibits heterogeneous nofluorescence was done first as a way of verifying that asparagine-linked glycosylation (N-glycosylation) in GCR33 is expressed in detectable amounts during infec-
HCMV-infected HFFs tion. Because IgG nonspecifically binds to cytoplasmic inclusion (CI) structures in HCMV-infected cells via the
We next used Western immunoassays to identify the protein by size. Initial experiments with whole cell lysates Fc portion of the antibody molecule (Furukawa et al., 1975; Keller et al., 1976) , immunofluorescence was done gave high backgrounds of nonspecific immunoreactivity, so we used membrane preparations as an alternate and using F(ab) 2 fragments (prepared from the anti-33 antiserum as described under Materials and Methods) and potentially enriched source of material (see Materials and Methods). Membrane preparations (20 mg protein) F(ab)2-fluorochrome conjugates of the secondary antibodies.
from cells infected with wild-type HCMV or with D33, or from noninfected cells, were subjected to SDS-PAGE Results of the experiment are summarized in Fig. 3 . The rabbit F(ab) 2 anti-33 fragments showed a pattern of followed by Western immunoassay using anti-33 (Fig. 4 , ''Membranes''). Immunoreactive material (see asterisked fluorescence that localized to the region of the CI in wildtype HCMV-infected fibroblasts (Fig. 3A) . Fluorescence bar, Fig. 4 , lane 2), was detected in the preparation from WT-infected cells, but not in those from D33-infected in cells infected with the UL33 mutant virus, D33 (Fig.  3B) , or in noninfected cells (Fig. 3C ) was essentially at (Fig. 4, lane 3) or noninfected (Fig. 4, lane 1) cells. The broad size range of the immunoreactive material sugthe level of background. This infected-cell-specific fluorescence was not due to nonspecific binding of F(ab) 2 gested that it was heterogeneously glycosylated or aggregated, or both. To test for the presence of asparaginefragments (Fig. 3D) ; nor was it due to binding of residual Fc in the rabbit F(ab) 2 anti-33 preparation, as evidenced linked oligosaccharides, an amount of sample equal to that used in lanes 1-3 was treated with PNGase F (Tareby detection with an anti-F(ab) 2 reagent (Fig. 3E) but not with an anti-Fc reagent (Fig. 3F) . The typical pattern of ntino and Plummer, 1994) . This treatment yielded a strong new band in the WT HCMV-infected cell prepara-CI fluorescence by nonspecific IgG binding in wild-typeinfected cells is shown for comparison (Figs. 3G and 3H) . tion (Fig. 4 , lane 5) that was absent from both the D33-infected and noninfected cell preparations (Fig. 4 , lanes The juxtanuclear location and generally spherical shape of the nonspecific, Fc-binding CIs (Fig. 3J ) appeared to 6 and 4, respectively). The É43-kDa size of this band approximates the computer-predicted molecular weight be the same as the pattern of specific binding by the rabbit F(ab) 2 anti-33 fragments, shown in the same field same extent and (ii) insertion of lacZ into the UL33 ORF was not deleterious to expression of the adjacent UL32 ORF. We have not further investigated the possible overexpression of BPP in D33-infected cells (i.e., see Fig. 4 ; compare lane 8 with lane 9). These data indicate that GCR33 is a heterogeneously N-glycosylated protein in HCMV-infected cells.
HCMV-infected cell-specific GCR33 shows peptide similarities to rBV-expressed pUL33
Peptide comparisons were used to establish that the anti-33-reactive, infected-cell-specific protein (Fig. 4 , lanes 2 and 5) is GCR33. Membranes from HCMV-infected HFF cells (treated or not treated with PNGase F) or rBV-33-infected insect cells were subjected to SDS -PAGE, followed by in situ protein cleavage with NCS, separation of the resulting peptides in a second-dimension gel, and finally Western immunoassay with anti-33 to identify related peptides, all as explained under HCMV-infected-cell GCR33 (with or without PNGase F protein product of HCMV UL32 ORF) (Greis et al., 1994) . The asterisked treatment) and rBV-33-infected-cell pUL33 provides dibar represents a molecular weight range of É58 to É100 kDa; molecurect evidence that the anti-33 reactive HCMV-infectedlar weight (in kDa) was estimated from molecular weight markers incell protein is the product of the UL33 ORF.
cluded during SDS -PAGE that were visualized by staining that portion of the Immobilon-P with CBB immediately following electrotransfer.
HCMV enveloped virus particles contain glycosylated GCR33 level of immunoreactivity observed in the PNGase Ftreated HCMV-infected cell preparation (Fig. 4, lane 5) Because GCRs are membrane proteins, enveloped virus particles were examined for the presence of GCR33 likely results from better electrotransfer of the 43-kDa deglycosylated protein from the gel, compared to the by SDS-PAGE and Western immunoassay. HCMV noninfectious enveloped particles (NIEP or N), virions (VIR or higher-molecular-weight glycosylated form (Fig. 4, lane  2) (Gibson, 1981a) , or to comparatively better retention of V), and dense bodies (DB or D) were prepared from WT HCMV-infected HFFs (WT) or from D33-infected (D33) the deglycosylated form on the Immobilon-P membrane (Gibson, 1981a) , or both. We attribute the small amount HFFs. A small portion of the pellet from each particle type was either treated or not treated with peptide Nof large, electrophoretically heterogeneous material that remained after PNGase F treatment (Fig. 4 , lane 5; also glycosidase F (//0 PNGase) and then tested by SDS -PAGE and Western immunoassay with the anti-33 antisesee Fig. 7 , lane 9) to incompletely deglycosylated GCR33 or the tendency of the protein to aggregate, or both.
rum (Fig. 6, anti-33 ). Although two background bands are present in all samples, detracting from the data, the antiWhole cell lysates (Fig. 4, ' 'Cells'') were also prepared (15 mg protein per lane) and subjected to SDS -PAGE in 33 antiserum specifically reacted with material in all three WT HCMV enveloped particles (indicated by cirthe same gel. Western immunoassays were done on these lysates to establish that the inability to detect a cles, Fig. 6 , lanes 5, 9, and 13) but in none of the corresponding D33 particles (Fig. 6, lanes 7, 11, and 15) . The UL33 protein in D33-infected cells was not due to a generally lower amount of protein in those preparations, diffuse pattern of anti-33 reactivity observed in the WT HCMV particles (Fig. 6 , circles, lanes 5, 9, and 13) was compared to WT-infected cells. An anti-peptide antiserum to the HCMV basic phosphoprotein (BPP, pp150, 149 consistent with that seen in membrane preparations from WT-infected cells (Fig. 4, lane 2; Fig. 6, lane 3) . Also as kDa, product of UL32 ORF) (Greis et al., 1994) was used and showed BPP in both D33-and WT-infected HFFs observed with the membrane preparations (Fig. 6, lane  4) , treatment of the WT particles with PNGase F (Fig. 6,  (Fig. 4, lanes 8 and 9, respectively) , indicating that (i) the D33 infections had progressed to approximately the lanes 6, 10, and 14) decreased the heterogeneity and qualitatively the same in both sets of particle preparations. Therefore, the absence of anti-33 reactivity with D33 particles seen in the anti-33 immunoassay (Fig. 6 , lanes 5 -16) was not due to a significantly reduced amount of D33 virus particles. The ratio of LM to miCP differed, however, between the WT and D33 particles, suggesting either that the D33 NIEP and virion preparations were partially contaminated with dense bodies or that the absence of GCR33 in some way altered the protein composition of these D33 particles. The antimiCP/anti-LM panel also demonstrates that the dense body preparations (Fig. 6, lanes 21 and 22) contained comparatively large amounts of LM but no miCP, as expected for these particles whose protein composition is approximately 90% LM and which contain no capsid structure or capsid protein constituents Irmiere and Gibson, 1983) . These experiments show that GCR33 is present in all three types of WT HCMV enveloped particles.
GCR33 from HCMV-infected cells and virus particles is larger than proteins expressed from UL33 or ''spliced UL33'' , 1995) . This spliced mRNA would F treatment were subjected to first-dimension SDS -PAGE in a single code for a variant of GCR33 extending 22 amino acids 12% polyacrylamide gel. The region of each sample spanning the size beyond the amino terminus of the protein encoded by range of GCR33 and pUL33 was excised from the gel, treated with the originally defined ORF (Chee et al., 1990b) . Because NCS to cleave the proteins in situ, and the resulting peptides were compared by SDS -PAGE in an 18% DATD-crosslinked polyacrylamide the recombinant pUL33, which lacks this amino extengel by electrophoresis perpendicular to the original direction of migrasion, migrates with a smaller apparent molecular weight tion (i.e., top to bottom), all as described under Materials and Methods.
than the deglycosylated GCR33 from WT HCMV-infected Peptides in the second-dimension gel were detected by Western immucells during SDS -PAGE, the possibility was tested that noassay with the anti-33 antiserum (to the carboxyl end of UL33 prothis discrepancy was due to the presence of an aminotein). Immunoreactive peptides are labeled 1 to 5. Circles indicate peptides 4 and 5 in lanes 1 and 2.
terminal extension on the protein made in WT HCMVinfected cells. An rBV (rBV-N33) was engineered that encodes the 22-amino-acid-extended splice variant of pUL33, called pUL33-XTND, for this purpose. size of the immunoreactive material to approximate the computer-predicted 43-kDa molecular weight of the pro-
The proteins produced by wild-type baculovirus (BV), rBV-33, rBV-N33, and wild-type HCMV were then comtein product of UL33.
As part of this experiment, a similar portion of each pared by SDS-PAGE and Western immunoassay using the anti-33 antiserum (Fig. 7) . Membrane preparations of the samples described above was solubilized more completely by heating in a boiling water bath prior to from WT HCMV-infected (WT-Inf.) or noninfected (Mock) cells were treated or not treated with PNGase F (//0 SDS-PAGE and was subjected to electrophoresis in the same gel. A Western immunoassay was done on these PNGase). As expected, pUL33-XTND (produced by rBV-N33, Fig. 7 , lanes 3, 4, and 5, circle) had a larger apparent samples with a mixture of a rabbit anti-peptide antiserum, called anti-miCP, against a capsid component, called the molecular weight (i.e., É39 kDa, versus É36 kDa) than the original pUL33 (Fig. 7, lane 2, circle) . The glycosylated ''minor capsid protein '' (miCP, pUL85) , and a mouse monoclonal antibody, called anti-LM, against an abunand deglycosylated GCR33 (Fig. 7 , lane 8, and Fig. 7 , circle, lane 9, respectively) migrated as in Fig. 4 , with dant tegument phosphoprotein called the ''lower matrix protein'' (LM or pp65, pUL83) (Fig. 6 , anti-miCP/anti-LM). apparent molecular weights of ¢58 and É43 kDa, respectively. No similar immunoreactive material was deThe reactivity of these antibodies with D33 particle preparations (Fig. 6, lanes 18, 20, and 22 ) and WT particle tected in WT baculovirus-infected cells (Fig. 7 , BV, lane 1) or noninfected HFFs (Fig. 7, lanes 6 and 7) . Thus, the preparations (Fig. 6, lanes 17, 19, and 21 ) demonstrated that the presence of the miCP and LM proteins was amino extension of pUL33-XTND does not fully account FIG. 6 . HCMV enveloped particles contain glycosylated GCR33. Cell membranes were isolated from noninfected (Mock; lanes 1 and 2) or WT HCMV-infected (WT; lanes 3 and 4) HFF cells. WT HCMV (WT; lanes 5, 6, 9, 10, 13, 14, 17, 19, and 21) or HCMV D33 (D33; lanes 7, 8, 11, 12, 15, 16, 18, 20, and 22) enveloped extracellular virus particles were used in these experiments; 17, and 18), 19, and 20) , or dense bodies (lanes 13 -16, 21, and 22) were purified from infected cells, treated or not treated with PNGase F (//0 PNGase), and subjected to SDS -PAGE, followed by Western immunoassay with rabbit anti-33. Circles (lanes 5, 9, and 13) indicate a broad, immunoreactive band of material in WT NIEPs, virions, and dense bodies. Another set of samples, not treated with PNGase F (lanes 17 -22), was heated in a boiling water bath prior to SDS -PAGE in the same gel and then subjected to Western immunoassay with a mixture of anti-miCP (to minor capsid protein) and anti-LM (to abundant lower matrix tegument protein). The positions of the minor capsid protein (miCP) and lower matrix protein (LM) are indicated; molecular weight (in kDa) was estimated from molecular weight markers included during SDS -PAGE that were visualized by staining that portion of the Immobilon-P with CBB immediately following electrotransfer.
for the discrepancy between the observed sizes of pUL33 particles, and (iv) is not essential for replication of HCMV in cell culture. and deglycosylated GCR33.
We have shown that pUL33 can be expressed from UL33 ORF is not essential for HCMV growth in cell rBVs in insect cells. Both the wild-type and T7-epitopeculture tagged forms (Kolodziej and Young, 1991) were excluded from the nucleus, but a more precise localization was To determine whether UL33 is required for HCMV repnot achieved due to the small cytoplasmic space in these lication in cell culture, we disrupted the UL33 gene by spherical Sf9 cells. rBV-encoded and in vitro-translated insertional mutagenesis (with the lacZ gene) and intropUL33 (data not shown) comigrated during SDS-PAGE, duced the mutant gene into the HCMV genome by homolwith an estimated size of 36 kDa (smaller than the comogous recombination, as described under Materials and puter-predicted 43 kDa). The electrophoretic mobility of Methods. A viable mutant, called D33, was selected on the rBV product was not affected by treatment with the basis of its blue-plaque phenotype. The time course PNGase F (data not shown), indicating that it is not appreof replication for D33 and WT HCMV were compared ciably glycosylated in insect cells. This finding was surunder single-cycle growth conditions (Fig. 8) . The results prising given that GCRs are typically N-glycosylated (Frashowed that D33 yields approximately the same titer of ser et al., 1994) and that insect cells are competent for progeny virus by 4 to 6 days after infection, but D33 titers the initial steps of this posttranslational modification were about 10-fold lower than those of WT HCMV at the (O'Reilly et al., 1992) ; the lack of glycosylation may relate four earlier time points (i.e., 16, 24, 48, and 72 hr after to interference with cellular N-glycosylation observed infection).
during the late stages of baculovirus infection (Jarvis and Summers, 1989) . Like other GCRs and highly hydropho-DISCUSSION bic proteins (Semenza et al., 1990) , pUL33 is heat sensiThe primary findings in this report are that the HCMV tive and aggregated when heated above 60Њ; aggregation GCR, GCR33 (i) is expressed from recombinant baculoviwas to the extent that essentially none of the protein rus in insect cells as a É36-kDa, heat-aggregatable prowas detected in the resolving gel when the sample was tein (pUL33) that is localized to nonnuclear regions of heated with solubilizing buffer in a boiling water bath. the cell, (ii) is present in HCMV-infected HFFs as a heterMore importantly, we have identified the UL33 GCR ogeneously N-glycosylated protein that localizes to the protein, GCR33, in HCMV-infected fibroblasts. Unlike resame region as the Fc-binding cytoplasmic inclusion, (iii) combinant pUL33, GCR33 in HCMV-infected cells was larger and more heterogeneous in size than the comis also present in three types of HCMV enveloped virus et al., 1995) that would give rise to a GCR33 that is 22 amino acids longer at its amino end than rBV pUL33. To test this last explanation, we cloned and expressed the ORF that would code for this splice variant from an rBV and found that, although larger than pUL33, as expected, it still migrated somewhat faster than deglycosylated GCR33 during SDS-PAGE (Fig. 7) . Thus, the protein detected in HCMV-infected HFFs differs in some way from the proteins expressed from both the spliced and nonspliced recombinant forms of UL33 tested here.
Glycosylated GCR33 is also present in virions and two types of enveloped virus particles called noninfectious enveloped particles and dense bodies. Because dense bodies are composed primarily of lower matrix protein surrounded by the viral envelope Irmiere and Gibson, 1983) , and GCRs are characteristically membrane proteins, this finding is consistent with GCR33 being a virus envelope glycoprotein. The presence of GCR33 in the viral envelope would allow for it being carried to cells with the virus and being deposited in the cellular plasma membrane with the rest of the viral envelope during entry. If introduced into the cell membrane by this mechanism, a functionally competent 2), or rBV-N33 (lanes 3, 4, and 5) were harvested 3 days after infection; membranes from noninfected (Mock; lanes 6 and 7) or WT HCMVinfected (WT-Inf.; lanes 8 and 9) HFFs were prepared and treated or not treated with PNGase F (//0 PNGase). Lane 4 (rBV-N33 1:1) is a twofold dilution, and lane 3 (rBV-N33 1:3) a fourfold dilution, of the material in lane 5. All samples were then analyzed by SDS -PAGE and Western immunoassay with the anti-33 antiserum. Circles indicate the three forms of the protein encoded by UL33. The asterisked bar indicates a broad molecular weight range of glycosylated GCR33 and aggregates of GCR33 that are visible near the top of the gel; molecular weights (in kDa) were estimated from molecular weight markers included during SDS -PAGE that were visualized by staining that portion of the Immobilon-P with CBB immediately following electrotransfer.
puter-predicted 43 kDa, due to asparagine-linked glycosylation. Treatment with PNGase F reduced the size to É43 kDa, close to the predicted size, but larger than the É36-kDa size of rBV pUL33. This mobility difference could be due to several causes. First, infected-cell GCR33 may bear additional modifications (Fraser et al., 1994) that are absent from the rBV product and possibly produced by infected-cell-specific enzymes. If such differences are present, they are not likely to be at the carboxyl end of GCR33 because peptide comparisons revealed no mobility differences among the five carboxy- coterminal peptides detected (Fig. 5) . Second, the recomMonolayers of MRC5 cells were infected with WT HCMV or D33 viruses binant protein may have an increased electrophoretic at a multiplicity of infection of 5 and washed three times with medium containing 10% FCS after adsorption. Supernatant virus was collected mobility due to misfolding (e.g., intramolecular hydrophoat 16, 24, 48, 72, 96 , and 144 hr after infection and was assayed by bic interactions of transmembrane domains) or incomplaquing on a fresh monolayer of MRC5 cells  plete denaturation. A third explanation is that the in- Kaye et al., 1992) . Duplicate assays were performed from duplicate fected-cell protein is actually larger. This possibility is infections for each time point. Shown here is a one-step growth curve; attractive in view of the recent finding that the UL33 standard errors were not greater than 6% between the two sets of measurements that were averaged.
mRNA exists in an additional spliced form (Davis-Poynter HCMV infection (Albrecht et al., 1991) , as suggested preits spliced mRNA show homology with known b-chemokine receptors (see FASTA scores, Table 1 ) (Kolakowski, viously (Welch et al., 1991) .
As shown in Fig. 3 , GCR33 localizes to the region of 1994). The longer amino terminus of the protein encoded by the spliced mRNA, GCR33-XTND (Davis-Poynter et al., the cytoplasmic inclusions (CIs). This result is intriguing, considering that GCRs normally appear at the cell sur-1995), would contain four more asparagine-linked glycosylation sites than GCR33, one more cysteine, and would face (Zastawny et al., 1994) . Several explanations could account for the predominant CI localization of GCR33.
have a slightly acidic charge, all characteristics of the amino termini of chemokine receptors (Ahuja and MurFirst, its distribution may not be accurately reflected by immunofluorescence. For example, plasma membranephy, 1993; Horuk, 1994; Murphy, 1994a,b) . Also, sequences in the second transmembrane domain and third localized GCR33 may be partially extracted or denatured during fixation and permeabilization; it may not be well transmembrane domain extending into the second intracellular loop are 55% homologous (18% identical) to presented for the antibodies to react; or it may be as abundant as it is in CIs, but less regionally concentrated, amino acid stretches found in those regions of chemokine receptors (Charo et al., 1994) . Thus, either the and hence less readily detected. A second explanation is that GCR33 has an intracellular function, perhaps in spliced or nonspliced mRNA from UL33 may encode a chemokine receptor (Table 1 ). addition to its surface role. HSV-1 glycoprotein gK offers a possible parallel in that it appears to localize predomiOther viral GCRs also show similarities to chemokine receptors. Both HCMV US28 and herpesvirus saimiri nantly intracellularly by immunofluorescence and yet is involved in syncytia formation, suggesting a surface loca-ECRF3 (Nicholas et al., 1992) encode functional chemokine receptors (Ahuja and Murphy, 1993; Gao and Murtion (Hutchinson et al., 1995) . Third, if GCR33 is a functional receptor, it may be internally sequestered as a phy, 1994; Kuhn et al., 1995; Neote et al., 1993; Vieira et al., 1995) . Human herpesviruses 6 and 7 (HHV-6 and -7), means of downregulating its activity (Fraser et al., 1994; Saffitz and Liggett, 1992; Zastawny et al., 1994) ; such a other members of the human b-herpesvirus group like HCMV, encode GCR homologues related to chemokine sequestration could hypothetically involve translocation of GCR33 from the cell surface to the CIs. A fourth explareceptors (Gompels et al., 1995) (Table 1) , and the rodent b herpesviruses murine CMV and rat CMV encode posination, based on the presence of GCR33 in enveloped virus particles, is that the protein may be targeted to this tionally conserved homologues of UL33 (Beisser et al., 1995; Davis-Poynter et al., 1995) . In addition, homologues region to be incorporated into maturing virions.
A ligand for GCR33
has not yet been identified, but the of chemokine receptors are encoded by the EpsteinBarr virus-induced cellular GCR mRNAs (Birkenbach et protein products from both its nonspliced and especially
